89bio, Inc. Quarterly Interest Expense in USD from Q1 2022 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
89bio, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2022 to Q2 2025.
  • 89bio, Inc. Interest Expense for the quarter ending June 30, 2025 was $1.14M, a 30.1% increase year-over-year.
  • 89bio, Inc. Interest Expense for the twelve months ending June 30, 2025 was $5.96M, a 67.2% increase year-over-year.
  • 89bio, Inc. annual Interest Expense for 2024 was $5.29M, a 10.3% increase from 2023.
  • 89bio, Inc. annual Interest Expense for 2023 was $4.79M, a 149% increase from 2022.
  • 89bio, Inc. annual Interest Expense for 2022 was $1.92M, a 185% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $5.96M $1.14M +$263K +30.1% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q1 2025 $5.69M $1.27M +$404K +46.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-02
Q4 2024 $5.29M $1.19M +$325K +37.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $4.97M $2.36M +$1.4M +146% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $3.56M $874K -$20K -2.24% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08
Q1 2024 $3.58M $863K -$1.21M -58.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-02
Q4 2023 $4.79M $866K +$321K +58.9% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $4.47M $959K +$424K +79.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $4.05M $894K +$460K +106% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $3.59M $2.08M +$1.67M +409% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.92M $545K Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $535K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $434K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $408K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.